Lowell, MA, United States of America

Alcyone Therapeutics, Inc.


USPTO Granted Patents = 7



Forward Citations = 7

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Deep Arjun Singh (7 out of 31 patents)

silverMedal P J Anand (5 out of 16 patents)

bronzeMedal Thomas T Washburn (4 out of 7 patents)

4.  Andrew William East (4 out of 13 patents)

5.  Jonathan Freund (2 out of 5 patents)

6.  Matthew J Lapinski (2 out of 7 patents)

7.  Burt Raymond (2 out of 2 patents)

8.  Megan Holmes (2 out of 2 patents)

9.  Pj Anand (1 out of 16 patents)

10.  Katelyn Perkins-Neaton (1 out of 3 patents)

11.  John L Mcguire (1 out of 1 patent)

12.  Andre Carline Wood (1 out of 1 patent)

13.  Krishna Subramanian (1 out of 1 patent)

14.  Rahul Veetekat (1 out of 1 patent)

15.  Chris Fleege (1 out of 1 patent)


7 patents:

Company Overview
Alcyone Therapeutics, Inc. is a biotechnology company focused on developing breakthrough gene therapies for rare genetic disorders. The company's innovative platform technology allows for precise targeting and delivery of therapeutic genes, offering hope to patients with currently untreatable conditions. With a strong track record of research and development, Alcyone Therapeutics is dedicated to improving the lives of those affected by genetic diseases.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#22 in Lowell, MA

#2,306 in Massachusetts

#39,929 in US

Lowell, MA (US)
Lowell, MA, United States of America
Forward Citations = 7

16 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alcyone Therapeutics, Inc.. Retrieved from https://idiyas.com/company/alcyone-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…